SecuringPharma.com

Latest News

EC seeks comment on GMP for active substances

The EC has published its latest concept paper designed to invite comment on the implementation of last year’s falsified medicines directive, this time looking at GMP for active substances.

Discovery of miltefosine fakes highlights need for simple assays

The discovery of counterfeit generic miltefosine capsules for the treatment of visceral leishmaniasis serves to underscore the urgent need for simple, inexpensive assays to evaluate medicines quality in the field.

Nigeria seeks mandatory life terms for medicine counterfeiters

The government of Nigeria is seeking a compulsory life sentence in jail for anyone found guilty of medicines counterfeiting, according to an article in the Tribune newspaper.

Pakistan shuts down pharma facility after deaths

The authorities in Pakistan have shut down a manufacturing facility in Punjab on suspicion of producing substandard and potentially spurious medicines that have killed dozens of people, according to local news reports.

US generic drug user fee proposals mean more facilities inspections

Manufacturers of APIs and finished dosage forms destined for the US market will be subject to more frequent inspections if Congress adopts the FDA's proposals for a new a Generic Drug User Fee Act.

Counterfeit antimalarials in Africa on the rise, caution scientists

Researchers are recommending "multiple parallel strategies" to stave off an alarming rise in fake and substandard antimalarials in Africa.

Earlier Headlines

Pharma cargo thefts decline in 2011

The number of thefts of pharmaceutical shipments declined significantly in 2011, with fewer cases and a much lower average value per incident, according to data compiled by security firm Freightwatch.

UK teen dies of Internet pill overdose

The dangers of ordering medicines over the Internet have once again been thrust into the limelight, following the death of an 18-year-old man in the UK.

US counterfeit drug seizures up 200 per cent in 2011

Seizures of counterfeit pharmaceuticals by US customs almost tripled in 2011 compared to the previous year, thanks in part to greater enforcement activity. The value of goods seized rose by $11m to reach $16.8m.

Drug shortages raising supply chain risk, says FDA

The US FDA has warned healthcare providers to be vigilant when sourcing injectable cancer medicines, because current shortages could encourage unscrupulous individuals to introduce unapproved and potentially counterfeit drugs into the supply chain.

Study reveals counterfeit medicine patterns in Brazil

Steroids and drugs for erectile dysfunction topped the list of counterfeited medicines seized by the authorities in Brazil between 2007 and 2010, says a new study.

Verify Brand unveils new traceability software version

Verify Brand has launched version 4.0 of its VB Enterprise software, designed to support serialisation initiatives and track-and-trace applications across the supply chain.